Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 275 of 427 entries
View as:

A Safety and Efficacy Study of Revlimid® 5 mg Capsules in Patients With Relapsed or Refractory Multiple Myeloma Who Have Received Long-term Treatment With it Under the Actual Condition of Use

Phase: N/A Priority: Normal
NCT ID: NCT02922543 Org: User:
Start: 02/18/11 End: 10/11/14 Due: 10/11/15

Study of Pomalidomide (CC-4047) to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effectiveness for Patients With Systemic Sclerosis With Interstitial Lung Disease

Phase: N/A Priority: Normal
NCT ID: NCT01559129 Org: User:
Start: 08/09/12 End: 11/03/16 Due: 11/03/17

Pharmacokinetics of Enasidenib (CC-90007) in Participants With Mild, Moderate and Severe Hepatic Impairment

Phase: N/A Priority: Normal
NCT ID: NCT04573582 Org: User:
Start: 11/13/20 End: 03/08/23 Due: 03/08/24

A Study to Evaluate the Efficacy, Drug Levels and Safety of Luspatercept (ACE-536) for the Treatment of Anemia Due to IPSS-R Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes in Chinese and Japanese Participants With Ring Sideroblasts Who Require Red Blood Cell Transfusions

Phase: N/A Priority: Normal
NCT ID: NCT04477850 Org: User:
Start: 11/30/20 End: 02/23/26 Due: 02/23/27

Study of the Combination of Lenalidomide and DTIC (Dacarbazine) in Patients With Metastatic Malignant Melanoma Previously Untreated With Systemic Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT00179608 Org: User:
Start: 09/01/05 End: 06/01/07 Due: 06/01/08

Observational Study of Lenalidomide in Subjects With Mantle Cell Lymphoma Who Failed Ibrutinib Treatment

Phase: N/A Priority: Normal
NCT ID: NCT02341781 Org: User:
Start: 04/30/15 End: 09/30/16 Due: 09/30/17

A Pharmacokinetics and Tolerability Study of Fedratinib in Subjects With Moderate and Severe Hepatic Impairment

Phase: N/A Priority: Normal
NCT ID: NCT03983161 Org: User:
Start: 09/04/19 End: 01/05/23 Due: 01/05/24

A Study of the First-line Treatment of Patients With Newly Diagnosed Transplant-ineligible Multiple Myeloma in Spain

Phase: N/A Priority: Normal
NCT ID: NCT03602755 Org: User:
Start: 07/19/18 End: 01/18/19 Due: 01/18/20

A Study to Evaluate the Safety of bb2121 in Subjects With High Risk, Newly Diagnosed Multiple Myeloma (NDMM)

Phase: N/A Priority: Normal
NCT ID: NCT04196491 Org: User:
Start: 05/27/20 End: 06/07/23 Due: 06/07/24

Study of Azacitidine to Evaluate Safety and Effectiveness for Chinese Patients With Higher Risk Myelodysplastic Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT01599325 Org: User:
Start: 07/24/12 End: 03/13/18 Due: 03/13/19

A Single Agent Phase II Study of Romidepsin (Depsipeptide, FK228) in the Treatment of Cutaneous T-cell Lymphoma (CTCL)

Phase: N/A Priority: Normal
NCT ID: NCT00106431 Org: User:
Start: 01/01/05 End: 12/01/08 Due: 12/01/09

Study to Evaluate the Pressor Effect of Oral Tyramine During Ozanimod Treatment in Healthy Adult Participants

Phase: N/A Priority: Normal
NCT ID: NCT04978298 Org: User:
Start: 07/19/21 End: 02/26/23 Due: 02/26/24

Study to Evaluate the Pharmacokinetic Comparability of CC-93538 From Two Different Drug Concentrations in Healthy Adult Subjects

Phase: N/A Priority: Normal
NCT ID: NCT04373187 Org: User:
Start: 06/22/20 End: 05/26/21 Due: 05/26/22

Study of Lenalidomide in Combination With Sunitinib to Evaluate the Safety and Efficacy in Patients With Renal Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT00975806 Org: User:
Start: 09/01/09 End: 10/01/11 Due: 10/01/12

Use Lenalidomide (Revlimid®) in Combination With Dexamethasone in Clinical Practice for the Treatment of Newly Diagnosed Multiple Myeloma (MM) Transplant Ineligible Patients

Phase: N/A Priority: Normal
NCT ID: NCT03001804 Org: User:
Start: 06/30/17 End: 12/16/22 Due: 12/16/23

An Extension to Study AZA PH GL 2003 CL 001 Allowing for Continuation of Azacitidine Treatment in Patients With Myelodysplastic Syndromes (MDS)

Phase: N/A Priority: Normal
NCT ID: NCT01186939 Org: User:
Start: 04/01/07 End: 09/01/09 Due: 09/01/10

A Study of Lenalidomide in Pediatric Subjects With Relapsed or Refractory Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT02538965 Org: User:
Start: 11/19/15 End: 01/11/19 Due: 01/11/20

Study of ACY-1215 Alone and in Combination With Bortezomib and Dexamethasone in Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT01323751 Org: User:
Start: 07/31/11 End: 12/03/16 Due: 12/03/17

A Study to Evaluate Gluten Challenge on Immune Responses in Subjects With Celiac Disease

Phase: N/A Priority: Normal
NCT ID: NCT03521180 Org: User:
Start: 05/11/18 End: 07/18/19 Due: 07/18/20

Study of CC-93269, a BCMA x CD3 T Cell Engaging Antibody, in Participants With Relapsed and Refractory Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT03486067 Org: User:
Start: 04/03/18 End: 03/18/25 Due: 03/18/26

Influence of Rifampin on the Pharmacokinetics of Romidepsin in Patients With Advanced Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01324323 Org: User:
Start: 04/01/11 End: 03/01/12 Due: 03/01/13

CC-223 and Ketoconazole Drug-Drug Interaction Study

Phase: N/A Priority: Normal
NCT ID: NCT01896323 Org: User:
Start: 07/01/13 End: 08/01/13 Due: 08/01/14

A Safety Study of CC-92252 in Healthy Adult Subjects and Adult Subjects With Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT03971825 Org: User:
Start: 07/24/18 End: 08/05/21 Due: 08/05/22

Safety and Efficacy Study of Abraxane as Maintenance Treatment After Abraxane Plus Carboplatin in 1st Line Stage IIIB / IV Squamous Cell Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02027428 Org: User:
Start: 02/11/14 End: 08/01/19 Due: 08/01/20

An Efficacy and Safety Study of Luspatercept (ACE-536) Versus Placebo in Adults Who Require Regular Red Blood Cell Transfusions Due to Beta (β) Thalassemia

Phase: N/A Priority: Normal
NCT ID: NCT02604433 Org: User:
Start: 05/02/16 End: 01/05/21 Due: 01/05/22